Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New wearable device aims to improve walking after stroke

NCT ID NCT06269367

Symptom relief Sponsor: University of Michigan Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a low-cost wearable device called NewGait to see if it can help stroke survivors walk better. Twenty chronic stroke survivors tried the device and a similar one, while researchers measured their walking speed and muscle activity. The goal is to create an affordable, easy-to-use tool for home rehabilitation.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
NewGait wearable limb orthotic device
What this could lead to
If it works, this could provide an affordable, easy-to-use device for stroke survivors to improve walking at home.
What could go wrong
This is a very small, early study (20 people) testing short-term effects only. It may not lead to lasting improvements or work for all stroke survivors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

20 people

The number who actually took part.

Started

Apr 2024

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Unilateral cortical or subcortical stroke * Chronic stroke (≥ 6 months) At least 6 months following their first unilateral stroke * Able to walk independently with/without assistive devices for 5-10 mins (\~150m) * No significant cognitive deficits as determined by the Mini Mental State Examination (MMSE) score (score≥ 22) Exclusion Criteria: * Cerebellar stroke * Traumatic or vascular brain injury * History of unstable heart condition, uncontrolled diabetes/hypertension * History of a recent lower-extremity trauma or fracture * History of a recent significant orthopedic or neurological conditions that could limit walking ability (e.g., multiple sclerosis, total knee replacement) * Documented history of significant spatial neglect * ankle joint contractures or significant spasticity in the lower limbs * History of a recent Botulinum Toxin (Botox) injection to the lower-extremity muscles (≤ 3 months) * Pregnant or actively planning to become pregnant (self-reported)- Inability to communicate or unable to consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stroke are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Stroke

Contacts and locations

Locations

  • Physical Medicine & Rehabilitation 325 E Eisenhower Pkwy Suite 3011

    Ann Arbor, Michigan, 48108, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.